ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,321.41
0.25%
Dow Jones
39,872.99
0.17%
US Dollar vs MXN
16.6099
-0.07%
Brent Oil
81.855
-0.72%
Bitcoin
69,877.74
-0.36%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Harrow Inc (HROW)

  7. Harrow Inc (HROW) Noticias

HROW

Harrow (HROW)

Harrow Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:HROW
FechaHoraFuenteTítuloSímboloCompañía
15/05/202406:00Business WireHarrow to Present at Two Investor Conferences in MayNASDAQ:HROWHarrow Inc
13/05/202415:01Business WireHarrow Announces First Quarter 2024 Financial ResultsNASDAQ:HROWHarrow Inc
13/05/202406:00Business WireHarrow Names Greg DiPasquale as Senior Vice President, Head of CommercialNASDAQ:HROWHarrow Inc
25/04/202406:00Business WireHarrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024NASDAQ:HROWHarrow Inc
02/04/202407:16Business WireMelt Pharmaceuticals Closes $24 Million Series B Preferred Stock FinancingNASDAQ:HROWHarrow Inc
20/03/202406:15IH Market NewsJPMorgan boosts dividends, Chipotle unveils 50:1 stock split, and Latest NewsNASDAQ:HROWHarrow Inc
19/03/202416:45Business WireHarrow Announces Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:HROWHarrow Inc
19/03/202406:27IH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:HROWHarrow Inc
06/03/202405:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
05/03/202406:00Business WireHarrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024NASDAQ:HROWHarrow Inc
15/02/202415:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HROWHarrow Inc
15/02/202415:01Business WireHarrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical ProductsNASDAQ:HROWHarrow Inc
09/02/202415:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HROWHarrow Inc
29/01/202414:26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:HROWHarrow Inc
29/01/202406:00Business WireHarrow Announces New Appointments to its Board of DirectorsNASDAQ:HROWHarrow Inc
11/01/202406:00Business WireHarrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye DiseaseNASDAQ:HROWHarrow Inc
03/01/202406:15Business WireMelt Pharmaceuticals Provides Corporate UpdateNASDAQ:HROWHarrow Inc
03/01/202406:00Business WireHarrow Partners with Leading Healthcare Market Access Technology PlatformsNASDAQ:HROWHarrow Inc
29/11/202306:00Business WireHarrow Completes Transfer of the TRIESENCE® New Drug ApplicationNASDAQ:HROWHarrow Inc
20/11/202306:00Business WireHarrow to Present at Two Investor Conferences in NovemberNASDAQ:HROWHarrow Inc
13/11/202315:38Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HROWHarrow Inc
13/11/202315:01Business WireHarrow Announces Third Quarter 2023 Financial ResultsNASDAQ:HROWHarrow Inc
30/10/202307:00Business WireHarrow Will Release Third Quarter 2023 Financial Results on November 13, 2023NASDAQ:HROWHarrow Inc
24/10/202306:00Business WireHarrow Completes Transfer of NDAs and Launches FLAREX®, NATACYN®, TOBRADEX® ST, VERKAZIA®, and ZERVIATE® in the U.S.NASDAQ:HROWHarrow Inc
29/09/202307:00Business WireHarrow Health, Inc. Changes Corporate Name to Harrow, Inc.NASDAQ:HROWHarrow Inc
26/09/202307:00Business WireMelt Pharmaceuticals Announces Exclusive Development and License Agreement with Catalent for Its Zydis® Fast-Dissolve Technology for Use in MELT-300 for Needle- and Opioid-Free Procedural SedationNASDAQ:HROWHarrow Inc
09/08/202315:01Business WireHarrow Announces Second Quarter 2023 Financial ResultsNASDAQ:HROWHarrow Inc
31/07/202306:00Business WireHarrow Launches VIGAMOX® in the U.S.NASDAQ:HROWHarrow Inc
26/07/202308:00Business WireHarrow to Announce Second Quarter 2023 Financial Results on August 9, 2023NASDAQ:HROWHarrow Inc
19/07/202316:19Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:HROWHarrow Inc
 Showing the most relevant articles for your search:NASDAQ:HROW

Su Consulta Reciente

NYSE
CVX
Chevron
CCOM
SILVER
SILVER
FX
USDMXN
US Dollar vs MXN
NASDAQ
GOOGL
Alphabet
COIN
SOLUSD
Solana
AMEX
XLV
Health Care Select Sector
NASDAQ
AAPL
Apple
NASDAQ
MSFT
Microsoft
NYSE
AXP
American Express
AMEX
XLF
Financial Select Sector
USOTC
BNPQY
BNP Paribas (QX)
NYSE
DIS
Walt Disney
USOTC
ADDYY
Adidas (QX)
USOTC
RHHBY
Roche (QX)
USOTC
BASFY
BASF (QX)
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados